Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-020959
Filing Date
2025-02-14
Accepted
2025-02-14 14:11:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14639
  Complete submission text file 0000950170-25-020959.txt   16574
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 88 TONGDA ROAD, TOUQIAO TOWN, GUANGLING DISTRICT YANGZHOU F4 225000
Business Address 88 TONGDA ROAD TOUQIAO TOWN, GUANGLING DISTRICT YANGZHOU F4 225000 (86) 0514-89800199
Meihua International Medical Technologies Co., Ltd. (Subject) CIK: 0001835615 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94742 | Film No.: 25626628
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)